Key facts
- It has raised $65.4M; the latest was Debt - General ($21.7M) in Jul 2024.
- Notable investors include MedTech Innovator, Innovationsstarter, Johnson & Johnson JJDC, Abiomed, Andreas Bremke — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Protembis
- ·The full record, as it builds
Funding rounds
No funding rounds for Protembis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Protembis
Operator of a medical device company intended to develop a minimally invasive and catheter-based filter device. The company's device minimizes the risk of brain injury as the filter blocks embolic debris from entering the blood vessels leading to the brain during cardiovascular interventions such as transcatheter aortic valve replacement procedures, enabling patients to enhance their quality of life and reduce overall healthcare costs associated with brain injury during surgical procedures.
- Sector
- Healthcare
- HQ
- Aachen, Germany
- Founded
- 2013
- Employees
- 13
- Website
- protembis.com/
- Ownership
- Privately Held (backing)
Protembis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Protembis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Protembis in its N-PORT filings yet. We sweep new filings monthly.